Just Biotherapeutics Secures $14,000,000 Series A Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=57b5a297-d22b-473a-958e-da0d5c0ac83b - Date
7/26/2016 - Company Name
Just Biotherapeutics - Mailing Address
401 Terry Avenue North Seattle, WA 98109 USA - Company Description
Just is an integrated design company focused on the technology of biotherapeutics, from molecule to manufacturing plant. We believe that technological innovation will accelerate biotherapeutic development and dramatically reduce the cost of these vital medicines. - Website
http://www.justbiotherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$14,000,000 - Transaction Round
Series A - Proceeds Purposes
The proceeds will support the completion of new lab space, pilot plant and GMP capabilities that will enable Just to accelerate the development of lower-cost biologics. - M&A Terms
- Venture Investor
Bill & Melinda Gates Foundation - Venture Investor
Merck Capital Ventures - Venture Investor
Lilly Asia Ventures - Venture Investor
ARCH Venture Partners
